[Experimental cochlear damage by neomycin ear drops]

E Yaniv1, R Kol

  • 1ENT Dept., Soroka Medical Center, Beer Sheba.

Harefuah
|May 15, 1991
PubMed

Insights

Neomycin ear drops can damage the cochlea in guinea pigs, affecting hearing. Even a single exposure damages supporting cells, leading to hearing loss.

Area of Science:

  • Ototoxicity
  • Auditory Neuroscience
  • Pharmacology

Background:

  • Neomycin sulfate is a common antibiotic used in ear drops.
  • Potential ototoxicity of neomycin sulfate necessitates investigation into its effects on the cochlea.

Purpose of the Study:

  • To evaluate the cochlear damage caused by neomycin sulfate solution at concentrations found in ear drops.
  • To determine the effects of varying exposure levels of neomycin sulfate on cochlear structures.

Main Methods:

  • Cochlear damage was assessed in 28 guinea pigs following exposure to neomycin sulfate solutions.
  • Control solutions included neomycin sulfate with dexamethasone sodium and physiologic salt solutions.

Main Results:

  • Neomycin sulfate solutions, but not controls, caused cochlear damage, even after a single exposure.
  • Initial damage targeted supporting cells, progressing to hair cell damage and hair loss with increased exposure.
  • Neomycin was absorbed from the middle ear to the inner ear, causing cochlear damage.

Conclusions:

  • Neomycin sulfate exhibits ototoxic properties, damaging the cochlea through absorption from the middle ear.
  • Damage to supporting cells and/or hair cells by neomycin sulfate leads to hearing loss.
  • Increased exposure duration to neomycin sulfate exacerbates cochlear damage and hearing impairment.

Related Concept Videos